Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Future perspectives in reconstructive surgery using tissue engineering.

A Atala1

  • 1Department of Urology, Children's Hospital, Boston, Massachusetts, USA. atala@a1.tch.harvard.edu

The Urologic Clinics of North America
|March 23, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of urology residency training between the United States and China.

Actas urologicas espanolas·2022
Same author

Ibuprofen loaded PLA nanofibrous scaffolds increase proliferation of human skin cells in vitro and promote healing of full thickness incision wounds in vivo.

Journal of biomedical materials research. Part B, Applied biomaterials·2015
Same author

Assessments of injectable alginate particle-embedded fibrin hydrogels for soft tissue reconstruction.

Biomedical materials (Bristol, England)·2013
Same author

Decellularization for whole organ bioengineering.

Biomedical materials (Bristol, England)·2013
Same author

Controlled heparin conjugation on electrospun poly(ε-caprolactone)/gelatin fibers for morphology-dependent protein delivery and enhanced cellular affinity.

Acta biomaterialia·2012
Same author

Embryoid body formation of human amniotic fluid stem cells depends on mTOR.

Oncogene·2009
Same journal

An Unprecedented Era of Innovation in Non-Muscle-Invasive Bladder Cancer.

The Urologic clinics of North America·2026
Same journal

Hubert Humphrey's Bladder Cancer: If He Could Have Time Traveled, Would that Have Changed the Outcome?

The Urologic clinics of North America·2026
Same journal

Key Clinical Trials Shaping the Future of Superficial High-Risk Bladder Cancer Management.

The Urologic clinics of North America·2026
Same journal

Future Directions: Artificial Intelligence and Digital Tools in Bladder Cancer Care.

The Urologic clinics of North America·2026
Same journal

Economic Considerations in the Management of Superficial Bladder Cancer.

The Urologic clinics of North America·2026
Same journal

Patient-Centered Approaches to Non-Muscle-Invasive Bladder Cancer Care.

The Urologic clinics of North America·2026
See all related articles

Tissue engineering offers a promising solution for urologic tissue reconstruction, addressing limitations of traditional methods. Early human applications show potential for treating conditions like vesicoureteral reflux and incontinence.

Area of Science:

  • Regenerative Medicine
  • Urology
  • Biomaterials Science

Background:

  • Current urologic tissue reconstruction often uses non-urologic tissues, leading to adverse effects.
  • Tissue engineering aims to create functional urologic tissues, including bladder, ureter, urethra, and genitalia.
  • Significant advancements in genitourinary tissue engineering have emerged in the past decade.

Purpose of the Study:

  • To review the progress and potential clinical applicability of tissue engineering in urology.
  • To highlight the requirements for successful human application of tissue engineering technologies.
  • To discuss early clinical outcomes and future directions in engineered urologic tissues.

Main Methods:

  • Review of current tissue engineering techniques for urologic applications.

Related Experiment Videos

  • Emphasis on cell culture facilities, cell processing (harvest, culture, expansion), and polymer design.
  • Analysis of initial human trials involving autologous cell injection for urologic conditions.

    • Main Results:

    • The first human application of cell-based tissue engineering for urologic repair has been achieved.
    • Successful correction of vesicoureteral reflux in children and urinary incontinence in adults using autologous cells.
    • Clinical trials for engineered bladder replacement are in development, indicating growing clinical relevance.

    Conclusions:

    • Engineered urologic tissues demonstrate emerging clinical applicability.
    • Tissue engineering holds significant promise for overcoming limitations of current reconstructive urologic procedures.
    • Continued research and development are crucial for advancing the clinical translation of tissue-engineered urologic constructs.